Rare Adult Subtype of Rhabdomyosarcoma, a Common Childhood Soft Tissue Carcinoma

Rhabdomyosarcoma is a malignant soft tissue sarcoma of primitive mesenchymal cells, showing varying degrees of striated skeletal muscle cell differentiation. It is a very common cancer of childhood and adolescence, but rarely seen in the adult population. Here, we present a case of a 33-year-old male presented with a poorly differentiated desmin positive alveolar rhabdomyosarcoma in the left arm. The prognosis of alveolar rhabdomyosarcoma in adults is very poor, frequently detected at advanced stages or with metastases. The alveolar subtype in particular has been found to have a more aggressive course with a high rate of metastasis. Recent studies have shown that using pediatric treatment guidelines resulted in better survival outcomes and local control, but the survival rates are still below that of the pediatric population. Newer studies are looking into using specific molecular markers for more targeted therapy in hopes of further improving survival rates in the adult population.

[1]  Andrew A. Dobitsch,et al.  Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  A. Ferrari,et al.  Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series , 2019, Medical Oncology.

[3]  Schandra Purnamawati,et al.  Adult Alveolar Rhabdomyosarcoma on Extremity, Successful Treatment with Radiotherapy following Chemotherapy: Serial Case Report , 2019, International journal of applied & basic medical research.

[4]  C. Fisher,et al.  Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  E. Fleuren,et al.  Targeted Therapy–based Combination Treatment in Rhabdomyosarcoma , 2018, Molecular Cancer Therapeutics.

[6]  D. Januszkiewicz-Lewandowska,et al.  Rhabdomyosarcoma in children - current pathologic and molecular classification. , 2018, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[7]  M. Arnold,et al.  Molecular diagnostics in the management of rhabdomyosarcoma , 2017, Expert review of molecular diagnostics.

[8]  Suresh C. Sharma,et al.  Adult rhabdomyosarcoma: Clinical presentation, treatment, and outcome. , 2015, Journal of cancer research and therapeutics.

[9]  Daniela Egas-Bejar,et al.  Rhabdomyosarcoma in adolescent and young adult patients: current perspectives , 2014, Adolescent health, medicine and therapeutics.

[10]  R. Lackman,et al.  Treatment of Adult Rhabdomyosarcoma , 2007, American journal of clinical oncology.

[11]  A. Ferrari,et al.  Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  G. Demetri,et al.  Response to Chemotherapy and Predictors of Survival in Adult Rhabdomyosarcoma , 2001, Annals of surgery.